Pals1 functions in redundancy with SMAP1 to inhibit Arf6 in order to prevent Rac1-dependent colorectal cancer cell migration and invasion.

Autor: Harms J; Medical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany., Lüttgenau SM; Medical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany., Emming C; Medical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany., Guske J; Medical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany., Weber K; Medical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany., Wagner T; Medical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany., Schowe L; Medical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany., Nedvetsky P; Medical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany., Krahn MP; Medical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany. Michael.Krahn@uni-muenster.de.
Jazyk: angličtina
Zdroj: Cancer gene therapy [Cancer Gene Ther] 2023 Mar; Vol. 30 (3), pp. 497-506. Date of Electronic Publication: 2022 Dec 09.
DOI: 10.1038/s41417-022-00570-2
Abstrakt: Downregulation of cell-cell adhesion and increased motility are prerequisites for the metastasis of cancer cells. We have recently shown that downregulation of the tight junction adapter protein Pals1 in colorectal cancer cells results in an increase of cell migration, invasion, and metastasis due to the enhanced activation of Arf6 and Rac1. We now reveal a redundancy between the Arf6-GAP SMAP1 and Pals1 in regulating Arf6 activity and thereby Rac1-dependent cell migration. The gene encoding SMAP1 is frequently disrupted in microsatellite instable colorectal cancer specimen and cell lines. In cells expressing SMAP1, deletion of Pals1 leads to disturbed formation of tight junctions but has no impact on Arf6 activity and cell migration. In contrast, inactivation of both SMAP1 and Pals1 results in enhanced Arf6/Rac1 activity and increased cell migration and invasion. Furthermore, analyzing patient cohorts, we found a significant decrease in patient's survival when both genes were downregulated, in contrast to cases, when expression of only one of both genes was affected. Taken together, we identified a redundancy between SMAP1 and Pals1 in the regulation of activation of Arf6/Rac1, thereby controlling cell migration, invasion, and metastasis of colorectal cancer cells.
(© 2022. The Author(s).)
Databáze: MEDLINE